Long non-coding RNAs ANRIL, THRIL, and NEAT1 as potential circulating biomarkers of SARS-CoV-2 infection and disease severity

[1]  Zübeyir Huyut,et al.  Effect of ferritin, INR, and D-dimer immunological parameters levels as predictors of COVID-19 mortality: A strong prediction with the decision trees , 2023, Heliyon.

[2]  M. Belyaev,et al.  Detection of Risk Predictors of COVID-19 Mortality with Classifier Machine Learning Models Operated with Routine Laboratory Biomarkers , 2022, Applied Sciences.

[3]  M. Zali,et al.  Detection of SARS-CoV-2 Genome in Stool and Plasma Samples of Laboratory Confirmed Iranian COVID-19 Patients , 2022, Frontiers in Molecular Biosciences.

[4]  A. Khatami,et al.  The expression patterns of MALAT-1, NEAT-1, THRIL, and miR-155-5p in the acute to the post-acute phase of COVID-19 disease , 2022, The Brazilian Journal of Infectious Diseases.

[5]  C. Mertoğlu,et al.  What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality? , 2022, International Immunopharmacology.

[6]  P. Finn,et al.  Long non-coding RNAs (lncRNAs) NEAT1 and MALAT1 are differentially expressed in severe COVID-19 patients: An integrated single-cell analysis , 2022, PloS one.

[7]  Zübeyir Huyut,et al.  Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19 , 2021, International Immunopharmacology.

[8]  W. Wang,et al.  Non-Coding RNAs: Master Regulators of Inflammasomes in Inflammatory Diseases , 2021, Journal of inflammation research.

[9]  S. M. Raboni,et al.  NEAT1 and MALAT1 are highly expressed in saliva and nasopharyngeal swab samples of COVID‐19 patients , 2021, Molecular oral microbiology.

[10]  F. Forouzanfar,et al.  Prediction and analysis of microRNAs involved in COVID-19 inflammatory processes associated with the NF-kB and JAK/STAT signaling pathways , 2021, International Immunopharmacology.

[11]  M. Zali,et al.  Identification of plasma lncRNA-ATB levels in hepatitis B virus-related cirrhosis and non-cirrhotic chronic hepatitis B patients. , 2021, Virus research.

[12]  Mina Mobini Kesheh,et al.  Long noncoding RNAs in respiratory viruses: A review , 2021, Reviews in medical virology.

[13]  Mehmet Tahir Huyut,et al.  The effectiveness of blood routine parameters and some biomarkers as a potential diagnostic tool in the diagnosis and prognosis of Covid-19 disease , 2021, International Immunopharmacology.

[14]  A. Ghaemi,et al.  SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms , 2021, Frontiers in Immunology.

[15]  R. Basiri,et al.  Clinical features and disease severity in an Iranian population of inpatients with COVID-19 , 2021, Scientific Reports.

[16]  R. Deng,et al.  A study of differential circRNA and lncRNA expressions in COVID-19-infected peripheral blood , 2021, Scientific Reports.

[17]  Xuemei Sun,et al.  Long non-coding RNA THRIL inhibits miRNA-24-3p to upregulate neuropilin-1 to aggravate cerebral ischemia-reperfusion injury through regulating the nuclear factor κB p65 signaling , 2021, Aging.

[18]  R. Chatterjee,et al.  In silico analysis of altered expression of long non-coding RNA in SARS-CoV-2 infected cells and their possible regulation by STAT1, STAT3 and interferon regulatory factors , 2021, Heliyon.

[19]  Y. Arslan,et al.  How do routine laboratory tests change in coronavirus disease 2019? , 2020, Scandinavian journal of clinical and laboratory investigation.

[20]  A. Pourfathollah,et al.  Convalescent Plasma against COVID-19: A Broad-Spectrum Therapeutic Approach for Emerging Infectious Diseases , 2020, Microorganisms.

[21]  Yingfeng Zheng,et al.  The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID‐19 , 2020, Clinical and translational medicine.

[22]  G. Mosayebi,et al.  Cytokine profile and disease severity in patients with COVID-19 , 2020, Cytokine.

[23]  A. Viola,et al.  Age-severity matched cytokine profiling reveals specific signatures in Covid-19 patients , 2020, Cell Death & Disease.

[24]  H. Akhavan-Niaki,et al.  Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation , 2020, Life Sciences.

[25]  Eun-Kyeong Jo,et al.  COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis , 2020, bioRxiv.

[26]  Nicolas Carlier,et al.  Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients , 2020, Science.

[27]  N. Alajez,et al.  Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response , 2020, Genes.

[28]  L. García,et al.  Immune Response, Inflammation, and the Clinical Spectrum of COVID-19 , 2020, Frontiers in Immunology.

[29]  Michael Berk,et al.  Genetic gateways to COVID‐19 infection: Implications for risk, severity, and outcomes , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  Ya-Wei Zhang,et al.  Inhibition of long noncoding RNA MALAT1 suppresses high glucose-induced apoptosis and inflammation in human umbilical vein endothelial cells by suppressing the NF-κB signaling pathway. , 2020, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[31]  G. Kai,et al.  COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons , 2020, Cytokine & Growth Factor Reviews.

[32]  Jie Dong,et al.  Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients , 2020, Cell Host & Microbe.

[33]  Guanzhen Wang,et al.  Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters , 2020, Annals of translational medicine.

[34]  T. Jiang,et al.  Management and Treatment of COVID-19: The Chinese Experience , 2020, Canadian Journal of Cardiology.

[35]  Jiang-lin Xiang,et al.  Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID‐19) infected patients , 2020, British journal of haematology.

[36]  Q. Ye,et al.  The pathogenesis and treatment of the `Cytokine Storm' in COVID-19 , 2020, Journal of Infection.

[37]  C. Ding,et al.  Long Non-coding RNA THRIL Mediates Cell Growth and Inflammatory Response of Fibroblast-Like Synoviocytes by Activating PI3K/AKT Signals in Rheumatoid Arthritis , 2020, Inflammation.

[38]  Taojiao Wang,et al.  Clinical and immunologic features in severe and moderate Coronavirus Disease 2019. , 2020, The Journal of clinical investigation.

[39]  Ying Wang,et al.  COVID-19 infection: the perspectives on immune responses , 2020, Cell Death & Differentiation.

[40]  Yong Sun Lee,et al.  Non-Coding RNAs and Their Role in Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV) Infections , 2020, Viruses.

[41]  Chuan Qin,et al.  Dysregulation of immune response in patients with COVID-19 in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  Y. Zhang,et al.  Therapeutic effect of subcutaneous injection of low dose recombinant human granulocyte-macrophage colony-stimulating factor on pulmonary alveolar proteinosis , 2020, Respiratory research.

[43]  Yan Zhang,et al.  Upregulated lncRNA THRIL/TNF-α Signals Promote Cell Growth and Predict Poor Clinical Outcomes of Osteosarcoma , 2020, OncoTargets and therapy.

[44]  Weidong Zhu,et al.  Mechanisms and Functions of Long Non-Coding RNAs at Multiple Regulatory Levels , 2019, International journal of molecular sciences.

[45]  Zhonghui Zhao,et al.  Identification of an Interferon-Stimulated Long Noncoding RNA (LncRNA ISR) Involved in Regulation of Influenza A Virus Replication , 2019, International journal of molecular sciences.

[46]  Jianhong Lu,et al.  Differential expression profiling of lncRNAs related to Epstein‐Barr virus infection in the epithelial cells , 2019, Journal of medical virology.

[47]  M. Lindsay,et al.  Long Non-Coding RNAs and the Innate Immune Response , 2019, Non-coding RNA.

[48]  Xiaolu Yang,et al.  The lncRNA Neat1 promotes activation of inflammasomes in macrophages , 2019, Nature Communications.

[49]  Juan Zhang,et al.  Targeting of IL-6-Relevant Long Noncoding RNA Profiles in Inflammatory and Tumorous Disease , 2019, Inflammation.

[50]  W. Hou,et al.  Long noncoding RNA MALAT1 releases epigenetic silencing of HIV-1 replication by displacing the polycomb repressive complex 2 from binding to the LTR promoter , 2019, Nucleic acids research.

[51]  A. Rice,et al.  HIV-1 replication in CD4+ T cells exploits the down-regulation of antiviral NEAT1 long non-coding RNAs following T cell activation. , 2018, Virology.

[52]  Yi Chen,et al.  Long non‐coding RNA NEAT1 plays an important role in sepsis‐induced acute kidney injury by targeting miR‐204 and modulating the NF‐&kgr;B pathway , 2018, International immunopharmacology.

[53]  M. Matsuoka,et al.  Long Noncoding RNA ANRIL Supports Proliferation of Adult T-Cell Leukemia Cells through Cooperation with EZH2 , 2018, Journal of Virology.

[54]  M. Luo,et al.  ZIKV infection effects changes in gene splicing, isoform composition and lncRNA expression in human neural progenitor cells , 2017, Virology Journal.

[55]  Y. Jiao,et al.  Long noncoding RNA MALAT-1 is a novel inflammatory regulator in human systemic lupus erythematosus , 2017, Oncotarget.

[56]  Sunantha Sethuraman,et al.  microRNA dependent and independent deregulation of long non-coding RNAs by an oncogenic herpesvirus , 2017, PLoS pathogens.

[57]  F. Swirski,et al.  Cytokine storm and sepsis disease pathogenesis , 2017, Seminars in Immunopathology.

[58]  C. Ding,et al.  Roles of LncRNAs in Viral Infections , 2017, Front. Cell. Infect. Microbiol..

[59]  Zhiguo Li,et al.  Overexpression of long noncoding RNA, NEAT1 promotes cell proliferation, invasion and migration in endometrial endometrioid adenocarcinoma. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[60]  Z. Fang,et al.  Long non-coding RNA MALAT-1 modulates metastatic potential of tongue squamous cell carcinomas partially through the regulation of small proline rich proteins , 2016, BMC Cancer.

[61]  G. Manning,et al.  Necroptosis and Inflammation. , 2016, Annual review of biochemistry.

[62]  Zicai Liang,et al.  Long non-coding RNA ANRIL regulates inflammatory responses as a novel component of NF-κB pathway , 2016, RNA biology.

[63]  J. Ouyang,et al.  lncRNAs regulate the innate immune response to viral infection , 2015, Wiley interdisciplinary reviews. RNA.

[64]  James A. Heward,et al.  Long non-coding RNAs in the regulation of the immune response , 2014, Trends in Immunology.

[65]  A. Iwasaki,et al.  Innate immunity to influenza virus infection , 2014, Nature Reviews Immunology.

[66]  Binyuan Jiang,et al.  The role of MALAT1 correlates with HPV in cervical cancer , 2014, Oncology letters.

[67]  C. Rice,et al.  Interferon-stimulated genes: a complex web of host defenses. , 2014, Annual review of immunology.

[68]  Yutaka Suzuki,et al.  Long noncoding RNA NEAT1-dependent SFPQ relocation from promoter region to paraspeckle mediates IL8 expression upon immune stimuli. , 2014, Molecular cell.

[69]  Zhonghan Li,et al.  The long noncoding RNA THRIL regulates TNFα expression through its interaction with hnRNPL , 2013, Proceedings of the National Academy of Sciences.

[70]  Xing Chen,et al.  Novel human lncRNA-disease association inference based on lncRNA expression profiles , 2013, Bioinform..

[71]  Denise P Barlow,et al.  Gene regulation by the act of long non-coding RNA transcription , 2013, BMC Biology.

[72]  K. Jeang,et al.  NEAT1 Long Noncoding RNA and Paraspeckle Bodies Modulate HIV-1 Posttranscriptional Expression , 2013, mBio.

[73]  H. Rakugi,et al.  ANRIL: Molecular Mechanisms and Implications in Human Health , 2013, International journal of molecular sciences.

[74]  F. Zhang,et al.  Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation , 2012, Medical Oncology.

[75]  Rory Johnson.  Long non-coding RNAs in Huntington's disease neurodegeneration , 2012, Neurobiology of Disease.

[76]  T. Katsuya,et al.  Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B. , 2012, Atherosclerosis.

[77]  Mesut Remzi,et al.  The relationship between Prostate CAncer gene 3 (PCA3) and prostate cancer significance , 2012, BJU international.

[78]  Howard Y. Chang,et al.  Molecular mechanisms of long noncoding RNAs. , 2011, Molecular cell.

[79]  P. Row,et al.  Post-translation modification of proteins; methodologies and applications in plant sciences. , 2011, Phytochemistry.

[80]  Howard Y. Chang,et al.  Long noncoding RNAs and human disease. , 2011, Trends in cell biology.

[81]  M. Esteller,et al.  Epigenetic modifications and human disease , 2010, Nature Biotechnology.

[82]  Jonathan C. Cohen,et al.  A Common Allele on Chromosome 9 Associated with Coronary Heart Disease , 2007, Science.

[83]  M. Karin,et al.  A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas , 2007, Oncogene.

[84]  Francisco Martinez-Murillo,et al.  Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise , 2004, Nature Genetics.

[85]  Daishi Tian,et al.  Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China , 2020 .

[86]  World Health Organization,et al.  Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance , 2020, Pediatria i Medycyna Rodzinna.

[87]  Jongchan Kim,et al.  Long noncoding RNA , 2019 .

[88]  V. Tergaonkar,et al.  Noncoding RNAs: Master Regulators of Inflammatory Signaling. , 2018, Trends in molecular medicine.

[89]  E. Fodor,et al.  Influenza virus replication , 2002 .